Hemolytic anemia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 19: Line 19:
|-
|-
! scope="row" | Etiology
! scope="row" | Etiology
| [[Bleeding]], [[thrombosis]], [[Necrosis|skin necrosis]]
| Drug-induced, immune-mediated, non-immune-mediated, infections, rheumatologic disease
| [[Bleeding]], [[thrombosis]], [[petechiae]], [[sepsis]]
| [[Bleeding]], [[thrombosis]], [[petechiae]], [[sepsis]]
| [[Renal failure]], [[hematuria]], [[bleeding]], [[microangiopathic hemolytic anemia]]
| [[Renal failure]], [[hematuria]], [[bleeding]], [[microangiopathic hemolytic anemia]]
Line 29: Line 29:
|-
|-
! scope="row" | Mean corpuscular volume
! scope="row" | Mean corpuscular volume
| Low but usually more than 20000 per microliter
| Normocytic (80-100 femtoliter)
| Low
| Low
| Low
| Low
Line 39: Line 39:
|-
|-
! scope="row" | Laboratory abnormalities
! scope="row" | Laboratory abnormalities
| Normal
| Indirect hyperbilirubinemia
| Elevated
| Elevated
| Normal
| Normal

Revision as of 02:48, 3 October 2017

Hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI Scan

Echocardiography or Ultrasound

Imaging Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic anemia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic anemia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic anemia differential diagnosis

CDC on Hemolytic anemia differential diagnosis

Hemolytic anemia differential diagnosis in the news

Blogs on Hemolytic anemia differential diagnosis

Directions to Hospitals Treating Hemolytic anemia

Risk calculators and risk factors for Hemolytic anemia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differentiating Hemolytic anemia from other Diseases

Characteristic/Parameter Hemolytic anemia Sideroblastic anemia Anemia of chronic disease Thalassemia Iron-deficiency anemia Erythropoietin deficiency Vitamin B12 deficiency Folate deficiency
Etiology Drug-induced, immune-mediated, non-immune-mediated, infections, rheumatologic disease Bleeding, thrombosis, petechiae, sepsis Renal failure, hematuria, bleeding, microangiopathic hemolytic anemia Renal failure, hematuria, bleeding, microangiopathic hemolytic anemia Petechiae, bleeding, other autoimmune diseases Petechiae, purpura, ecchymoses Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis
Mean corpuscular volume Normocytic (80-100 femtoliter) Low Low Low Low; can be as low as 10000 per microliter Low; can be less than 10000 per microliter; sudden onset after transfusion Variable; usually low Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis
Laboratory abnormalities Indirect hyperbilirubinemia Elevated Normal Normal Normal Normal Usually normal Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis
Physical exam Heparin exposure Sepsis, delivery of fetus, acute promyelocytic leukemia, other malignancy E.coli strain O157:H7; Shiga-like toxin Dysregulation of complement activation; mutation in complement factor H Idiopathic; can be secondary to chronic lymphocytic leukemia, HIV, viral hepatitis, H. pylori Exposure to transfused products Autoimmunity with development of antibodies to DNA Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis
Treatment Yes, always Possible No No Yes No; transfusion-related Possible; drug-induced lupus can be caused by medications like hydralazine or isoniazid Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis
Other associated abnormalities Possible Usually Usually Usually Yes; spontaneous bleeding if platelet count < 10000 per microliter Yes; spontaneous bleeding if platelet count < 10000 per microliter Rare Bleeding, photosensitivity, arthritis, malar rash, discoid rash, renal failure, seizures, psychosis

References

Template:WS Template:WH